Cargando…
Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
OBJECTIVES: Surveillance drug resistance mutations (SDRMs) in drug-naive patients are typically used to survey HIV-1-transmitted drug resistance (TDR). We test here how SDRMs in patients failing treatment, the original source of TDR, contribute to assessing TDR, transmissibility and transmission sou...
Autores principales: | Winand, Raf, Theys, Kristof, Eusébio, Mónica, Aerts, Jan, Camacho, Ricardo J., Gomes, Perpetua, Suchard, Marc A., Vandamme, Anne-Mieke, Abecasis, Ana B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570689/ https://www.ncbi.nlm.nih.gov/pubmed/26355575 http://dx.doi.org/10.1097/QAD.0000000000000811 |
Ejemplares similares
-
Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations
por: Theys, Kristof, et al.
Publicado: (2016) -
Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations
por: Pingarilho, Marta, et al.
Publicado: (2020) -
Drivers of HIV-1 transmission: The Portuguese case
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2019) -
Functional conservation of HIV-1 Gag: implications for rational drug design
por: Li, Guangdi, et al.
Publicado: (2013) -
TYRP1 mRNA level is stable and MITF-M-independent in drug-naïve, vemurafenib- and trametinib-resistant BRAF(V600E) melanoma cells
por: Hartman, Mariusz L., et al.
Publicado: (2019)